scispace - formally typeset
S

Sheng-Nan Lu

Researcher at Chang Gung University

Publications -  343
Citations -  12771

Sheng-Nan Lu is an academic researcher from Chang Gung University. The author has contributed to research in topics: Hepatitis B virus & Hepatocellular carcinoma. The author has an hindex of 49, co-authored 338 publications receiving 11516 citations. Previous affiliations of Sheng-Nan Lu include Memorial Hospital of South Bend.

Papers
More filters
Journal ArticleDOI

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

TL;DR: Elevated serum HBV DNA level (> or =10,000 copies/mL) is a strong risk predictor of hepatocellular carcinoma independent of HBeAg, serum alanine aminotransferase level, and liver cirrhosis.
Journal ArticleDOI

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma

TL;DR: For HCC patients in BCLC very early/early stage, there was no significant difference in OS between SR and RFA, however, SR yielded better DFS than RFA in DFS.
Journal ArticleDOI

Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

TL;DR: It is suggested that environmental aflatoxin exposure may enhance the hepatic carcinogenic potential of hepatitis B virus and a large‐scale study will be needed to evaluate the effect of a flatoxin exposure on HBsAg non‐carriers.
Journal ArticleDOI

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis.

TL;DR: Cirrhosis can be predicted well by US, especially in patients with chronic hepatitis B virus (HBV) or C virus (HCV) infection.